Flaxseed are particularly abundant source of phytoestrogens, are diphenolic compounds that are present in several plants eaten by human beings. When ingested in relatively large amounts, phytoestrogens have been shown to have significant estrogen agonists/ antagonists effects in animals and humans. There is epidemiological, laboratory and clinical evidence which indicates that phytoestrogens, like certain selective estrogen receptor modulators, have an antiproliferative effect on the breast, and positive effects on the lipoprotein profile and bone density. They might also improve some of the climacteric symptoms. This evidence is critically reviewed, and the possible benefit of dietary intervention with phytoestrogen-rich food for woman's health is discussed. Keywords: Phytoestrogens. Menopause. Lipoproteins. Selective Estrogen Receptor Modulators.
INTRODUCTION
Exogenous estrogens and phytoestrogens given to postmenopausal women cause rapid alleviation off menopausal symptoms, and reduce the risk of heart disease 1 . Nevertheless, in most western countries only 10-15% of postmenopausal women are current users of hormone replacement therapy (HRT). Women are reluctant to use HRT mainly due to undesirable side-effects (such as irregular bleeding) and concerns about safety (especially possible increased risk of breast cancer). Therefore, there is recently a global effort to develop preparations that would yield the benefits of HRT with minimal inconvenience or risks 2 . Hormonal treatment for postmenopausal women is aimed in two major directions: 1 alleviation of undesired estrogens. This name was given long before SERMs were menopausal symptoms and 2 prevention of metabolic identified. Today it seems that there is even higher degree processes which may lead to morbidity in older age. Selective estrogen receptor mudulators (SERMs) are possibly a new alternative for postmenopausal therapy 3 . In this review evidence will be presented that dietary phytoestrogen is a group of compounds with SERM-like activity, that might be considered as another alternative to HRT.
CLASSIFICATION AND BIOLOGICAL ACTIVITY AND EPIDEMIOLOGY
Phytoestrogen (PE) is a general term used to define classes of compounds that are non-steroidal and are either of plant origin or derived from the in vivo metabolism of precursors present in several plants eaten by human beings. The one classe of these compounds are the lignans. Flaxseed is particularly abundant source of phytoestrogens. In humans, after consumption of plant lignans, enzymatic metabolic conversions occur in the gut, resulting in the formation of heterocyclic phenols 4,5,6 . These compounds structurally resemble estrogen and were shown to have weak estrogenic activity, and therefore were named phyto (plant) estrogens. This name was given long before SERMs were identified. Today it seems that there is even higher degree of structural resemblance to certain SERMs (e.g. raloxifene).
Phytoestrogens appear to have both estrogenic and antiestrogenic effects, like SERMs, depending on the concentrations of circulating endogenous estrogens and estrogen receptors. The estrogenic effects of phytoestogens Thais de Rezende Bessa Guerra, Gilson Teles Boaventura, Luis Guillermo Coca Velarde.
were first observed as reproductive disturbances in sheep 7 . We recently observed a marked increase in serum levels of SHBG in women who consumed a phytoestrogen rich diet. This increase might be looked upon as a determinant of estrogenic activity 8 . Phytoestrogens were also shown to have estrogen and antiestrogen vitro effects: similar to estrogen they bind to estrogen receptors 9,10,11 and increase the synthesis of SHBG by liver cells 12 , but, like antiestrogens, they inhibit aromatase activity, and the proliferation of breast cancer cells.
Lignans are found widely in cereals, fruit and vegetables. They occur in high concentrations in flaxseed and in lesser concentrations in whole grain and seeds. Vegetarians have the highest excretion values of isoflavones and lignans 13, 14 . The traditional oriental diet is [unpublished] . rich in phytoestrogens. In Japan, the typical diet is low-fat with much rice, soy products, fish and vegetables. Japanese men and women consuming a traditional Japanese diet have very high blood and urine concentrations of phytoestrogens, especially isoflavones 15 . Asian populations such as those in Japan, Taiwan and Korea, are estimated to consume 20-150 mg/day of lignans. 14 Epidemiologic data indicate that Japanese women complain much less of climacteric symptoms, especially hot ushes, as compared to western women 16 . Furthermore, the incidence of hormone dependent cancer in Japan is significantly lower than in western countries women have very low incidence of breast cancer 17 . This lower in women in low incidence substantially increases once they westernize their diet. It has been suggested that the high concentrations of phytoestrogen may partially explain the apparently low incidence of hot ushes and breast cancer in Japanese women. This hypothesis was supported by the finding of a case-control study that in western women, an inverse relationship exists between the blood levels of certain phytoestrogens (especially equol) and the risk of beast cancer. 18
INFLUENCE OF PHYTOESTROGENS AND CANCER
In cancer rate have been partially attributed to differences in dietary intake. It has been suggested that consumption of phytoestrogens may contribute to the relatively low rate of breast, prostate, and colon cancer in countries such as China and Japan. Laboratory animals fed with fortified diets, have predominantly less breast tumors proliferation after stimulation with tumor inducing agents (such as DMBA) PEs also exhibit antiproliferative effects in other malignant cells and tissues. 19 The effect lignan has been attributed to a competitive inhibition by occupying estrogen receptors or to inhibition of several key enzymes, especially tyrosine kinase 20 which is thought to be involved in the control of cell proliferation and carcinogenesis 21 . Protein-tyrosine kinase activity is associated with cellular receptors for growth and differentiation, promoting factors and plays a key role along this signal transduction pathway. We recently found that the anti-proliferative effects of genistein occur also in estrogen-receptors negative breast cancer cell-lines (such as MDA 231 and MDA 435). 22
INFLUENCE OF PHYTOESTROGENS AND MENOPAUSE
The postmenopause and the climacteric are associated with vasomotor symptoms and increased risk of osteoporosis and cardiovascular disease 19 . The frequency of climacteric symptoms and the incidence of osteoporosis and heart disease are reduced in Asian countries. There are evidence that high intake of phytoestrogens may contribute to these findings. 23
Climacteric symptoms
The climacteric symptoms severity and frequency of vasomotor symptoms, especially hot ushes, are reportedly lower in women in southeast Asia as compared to western women 24 . These differences have been attributed to social and racial characteristics, life-style, and diet. The role of diet is characteristics, life-style, and diet 25 . The role of diet is recently attracting increasing interest. It has been hypothesized that the content of natural estrogenic substances such as phytoestrogens in their food may partially explain this phenomenon. There are very few controlled clinical trails which investigated the effects of phytoestrogens on climacteric symptoms. Baird et al. 26 did not find any beneficial effect of the phytoestrogens on menopausal symptomatology in a 4-week study. Such an effect might have been shown if the occurrence of hot ushes when the diet of postmenopausal women was supplemented with phytoestrogens or wheat ours for 12 weeks. At 6 weeks the phytoestrogens diet yielded better results (i.e. reduced the number of hot ushes per day more significantly than the wheat diet). In a more recent study Albertazzi et al. 27 ; found that phytoestrogens was significantly superior to placebo in reducing the mean number of hot ushes per 24 h after 4, 8 and 12 weeks of treatment.
Cardiovascular disease
PE consumption might contribute to the lower incidence of cardiovascular disease in Asian countries and in vegetarians. There is now sufficient evidence to support the observation that phytoestrogen-rich diet has a beneficiary on serum lipoproteins profile. Soy protein supplementation to Rhesus monkeys results in hypocholesterolemic effect when compared with soy diet depleted of phytoestrogens 28, 29 . The HDL: cholesterol ratio increased 50% in female monkeys and 20% in the males. A meta-analysis 30 of 38 published controlled clinical trials soy protein consumption was associated significantly with mean reductions in total cholesterol, LDL-cholesterol and triglycerides. In a our recent study of postmenopausal with PE-women supplemented with 20-mg phytoestrogen capsules may we found a 24% reduction in total cholesterol, and 18% increase in HDL (unpublished). The hypocholesterolemic effect of phytoestrogens may not be their only mechanism further pursuit of this line of investigation, of cardioprotection. It has been reported that soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques, similarly to estrogen postmenopausal women the SPE is. 31 The cardioprotective effect of the phytoestrogenrich diet has yet to be substantiated by long-term controlled of the soy molasses into a fine dried powder without clinical trails.
CONCLUSIONS
The data presented here indicate that, like SERMs, phytoestrogens have both estrogenic and antiestrogenic effects, depending on the specific tissue and the concentrations of circulating endogenous estrogens. The biological activity of phytoestrogens has been demonstrated mostly in animals and in in vitro studies, but they appear to have physiological effects in humans. The most supportive human data is related to the effects of PE on lipids, lipoproteins, and certain malignant diseases. The evidence we reviewed justifies concluding that phytoestrogens may be among the dietary factors affording the protective effects against heart disease and cancer in vegetarians. Mild estrogenic effects have been observed in postmenopausal women; however, it is too early to determine the clinical value of phytoestrogens in ameliorating the early postmenopausal symptoms. The results of epidemiological and in vitro studies regarding the inhibitory effects of phytoestrogens on the breast, are encouraging but extrapolating from these data to clinical practice must be done with caution. The apparent protective effect of phytoestrogens on the breast should be further examined by long-term clinical trails.
